CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Index level readings help identify whether markets are overbought or consolidating. This quick intro shows what high vs low levels mean for trend and risk.
27,260 articlesCRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
The dramatic shift policy just signaled by the Fed has set the stage for a new era in healthcare investing. Bristol M...
On June 20, 2026, a Ramsey Show–style caller received a blunt reality check about retirement planning after outlining...
Two cloud stock darlings sit at opposite ends of the growth vs profitability spectrum. This guide breaks down gitlab ...
Berkshire Hathaway under Greg Abel signals a sharper eye for AI champions. Could Alphabet be the catalyst, with Nvidi...
A remote panic in libp2p-gossipsub could crash any Ethereum node with a single message. The vulnerability, CVE-2026-3...
A new paid service promises ultra-fast access to high-profile Truth Social posts, including those from President Trum...
Intuitive Machines has sparked a sharp turn in its stock without a major news release. This article breaks down why i...
Jamie Dimon warns of parallels to the pre-financial crisis era as asset prices and volumes stay elevated. The JPMorga...
Oil has jumped on geopolitical fears, and investors wonder how this could affect their portfolios. This guide explain...
AI is reshaping big tech, but not all bets are the same. This guide weighs Microsoft and Amazon on AI power, cash flo...
Britannica and Merriam-Webster filed a lawsuit against OpenAI, alleging unauthorized use of their content to train AI...